id	sid	tid	token	lemma	pos
dpc-4232	1	1	dermatology	dermatology	NOUN
dpc-4232	1	2	:	:	PUNCT
dpc-4232	1	3	practical	practical	ADJ
dpc-4232	1	4	and	and	CCONJ
dpc-4232	1	5	conceptual	conceptual	ADJ
dpc-4232	1	6	research	research	NOUN
dpc-4232	1	7	letter	letter	NOUN
dpc-4232	2	1	|	|	ADV
dpc-4232	2	2	dermatol	dermatol	ADJ
dpc-4232	2	3	pract	pract	NOUN
dpc-4232	2	4	concept	concept	NOUN
dpc-4232	2	5	.	.	PUNCT
dpc-4232	3	1	2024;14(4):e2024224	2024;14(4):e2024224	NUM
dpc-4232	3	2	1	1	NUM
dpc-4232	3	3	association	association	NOUN
dpc-4232	3	4	of	of	ADP
dpc-4232	3	5	black	black	ADJ
dpc-4232	3	6	race	race	NOUN
dpc-4232	3	7	with	with	ADP
dpc-4232	3	8	demographic	demographic	ADJ
dpc-4232	3	9	,	,	PUNCT
dpc-4232	3	10	comorbidities	comorbiditie	NOUN
dpc-4232	3	11	,	,	PUNCT
dpc-4232	3	12	and	and	CCONJ
dpc-4232	3	13	outcome	outcome	VERB
dpc-4232	3	14	variables	variable	NOUN
dpc-4232	3	15	in	in	ADP
dpc-4232	3	16	localized	localized	ADJ
dpc-4232	3	17	scleroderma	scleroderma	NOUN
dpc-4232	3	18	patients	patient	NOUN
dpc-4232	3	19	:	:	PUNCT
dpc-4232	3	20	a	a	DET
dpc-4232	3	21	retrospective	retrospective	ADJ
dpc-4232	3	22	analysis	analysis	NOUN
dpc-4232	3	23	of	of	ADP
dpc-4232	3	24	 	 	SPACE
dpc-4232	3	25	the	the	DET
dpc-4232	3	26	2017	2017	NUM
dpc-4232	3	27	us	us	PROPN
dpc-4232	3	28	national	national	PROPN
dpc-4232	3	29	inpatient	inpatient	PROPN
dpc-4232	3	30	sample	sample	PROPN
dpc-4232	3	31	keshav	keshav	PROPN
dpc-4232	3	32	d.	d.	PROPN
dpc-4232	3	33	kumar1	kumar1	PROPN
dpc-4232	3	34	,	,	PUNCT
dpc-4232	3	35	amar	amar	PROPN
dpc-4232	3	36	d.	d.	PROPN
dpc-4232	3	37	desai1	desai1	PROPN
dpc-4232	3	38	,	,	PUNCT
dpc-4232	3	39	shari	shari	PROPN
dpc-4232	3	40	r.	r.	PROPN
dpc-4232	3	41	lipner2	lipner2	PROPN
dpc-4232	3	42	1	1	NUM
dpc-4232	3	43	rutgers	rutgers	PROPN
dpc-4232	3	44	new	new	PROPN
dpc-4232	3	45	jersey	jersey	PROPN
dpc-4232	3	46	medical	medical	PROPN
dpc-4232	3	47	school	school	PROPN
dpc-4232	3	48	,	,	PUNCT
dpc-4232	3	49	newark	newark	PROPN
dpc-4232	3	50	,	,	PUNCT
dpc-4232	3	51	nj	nj	PROPN
dpc-4232	3	52	,	,	PUNCT
dpc-4232	3	53	usa	usa	PROPN
dpc-4232	3	54	2	2	NUM
dpc-4232	3	55	department	department	NOUN
dpc-4232	3	56	of	of	ADP
dpc-4232	3	57	dermatology	dermatology	NOUN
dpc-4232	3	58	,	,	PUNCT
dpc-4232	3	59	weill	weill	PROPN
dpc-4232	3	60	cornell	cornell	PROPN
dpc-4232	3	61	medicine	medicine	PROPN
dpc-4232	3	62	,	,	PUNCT
dpc-4232	3	63	new	new	PROPN
dpc-4232	3	64	york	york	PROPN
dpc-4232	3	65	,	,	PUNCT
dpc-4232	3	66	ny	ny	PROPN
dpc-4232	3	67	,	,	PUNCT
dpc-4232	3	68	usa	usa	PROPN
dpc-4232	3	69	key	key	PROPN
dpc-4232	3	70	words	word	NOUN
dpc-4232	3	71	:	:	PUNCT
dpc-4232	3	72	localized	localized	ADJ
dpc-4232	3	73	scleroderma	scleroderma	NOUN
dpc-4232	3	74	,	,	PUNCT
dpc-4232	3	75	morphea	morphea	PROPN
dpc-4232	3	76	,	,	PUNCT
dpc-4232	3	77	linear	linear	ADJ
dpc-4232	3	78	scleroderma	scleroderma	NOUN
dpc-4232	3	79	,	,	PUNCT
dpc-4232	3	80	scleroderma	scleroderma	NOUN
dpc-4232	3	81	,	,	PUNCT
dpc-4232	3	82	race	race	NOUN
dpc-4232	3	83	,	,	PUNCT
dpc-4232	3	84	racial	racial	ADJ
dpc-4232	3	85	disparities	disparity	NOUN
dpc-4232	3	86	citation	citation	NOUN
dpc-4232	3	87	:	:	PUNCT
dpc-4232	3	88	kumar	kumar	PROPN
dpc-4232	3	89	kd	kd	PROPN
dpc-4232	3	90	,	,	PUNCT
dpc-4232	3	91	desai	desai	PROPN
dpc-4232	3	92	ad	ad	PROPN
dpc-4232	3	93	,	,	PUNCT
dpc-4232	3	94	lipner	lipner	PROPN
dpc-4232	3	95	sr	sr	PROPN
dpc-4232	3	96	.	.	PUNCT
dpc-4232	4	1	association	association	PROPN
dpc-4232	4	2	of	of	ADP
dpc-4232	4	3	black	black	ADJ
dpc-4232	4	4	race	race	NOUN
dpc-4232	4	5	with	with	ADP
dpc-4232	4	6	demographic	demographic	ADJ
dpc-4232	4	7	,	,	PUNCT
dpc-4232	4	8	comorbidities	comorbiditie	NOUN
dpc-4232	4	9	,	,	PUNCT
dpc-4232	4	10	and	and	CCONJ
dpc-4232	4	11	outcome	outcome	VERB
dpc-4232	4	12	variables	variable	NOUN
dpc-4232	4	13	in	in	ADP
dpc-4232	4	14	localized	localized	ADJ
dpc-4232	4	15	scleroderma	scleroderma	NOUN
dpc-4232	4	16	patients	patient	NOUN
dpc-4232	4	17	:	:	PUNCT
dpc-4232	4	18	a	a	DET
dpc-4232	4	19	retrospective	retrospective	ADJ
dpc-4232	4	20	analysis	analysis	NOUN
dpc-4232	4	21	of	of	ADP
dpc-4232	4	22	the	the	DET
dpc-4232	4	23	2017	2017	NUM
dpc-4232	4	24	us	us	PROPN
dpc-4232	4	25	national	national	PROPN
dpc-4232	4	26	inpatient	inpatient	PROPN
dpc-4232	4	27	sample	sample	NOUN
dpc-4232	4	28	.	.	PUNCT
dpc-4232	5	1	dermatol	dermatol	NOUN
dpc-4232	5	2	pract	pract	PROPN
dpc-4232	5	3	concept	concept	NOUN
dpc-4232	5	4	.	.	PUNCT
dpc-4232	6	1	2024;14(4):e2024224	2024;14(4):e2024224	NUM
dpc-4232	6	2	.	.	PUNCT
dpc-4232	6	3	doi	doi	PROPN
dpc-4232	6	4	:	:	PUNCT
dpc-4232	6	5	https://doi.org/10.5826/dpc.1404a224	https://doi.org/10.5826/dpc.1404a224	PROPN
dpc-4232	6	6	accepted	accept	VERB
dpc-4232	6	7	:	:	PUNCT
dpc-4232	6	8	may	may	AUX
dpc-4232	6	9	13	13	NUM
dpc-4232	6	10	,	,	PUNCT
dpc-4232	6	11	2024	2024	NUM
dpc-4232	6	12	;	;	PUNCT
dpc-4232	6	13	published	publish	VERB
dpc-4232	6	14	:	:	PUNCT
dpc-4232	7	1	october	october	PROPN
dpc-4232	7	2	2024	2024	NUM
dpc-4232	7	3	copyright	copyright	NOUN
dpc-4232	7	4	:	:	PUNCT
dpc-4232	7	5	©	©	PROPN
dpc-4232	7	6	2024	2024	NUM
dpc-4232	7	7	kumar	kumar	PROPN
dpc-4232	7	8	et	et	PROPN
dpc-4232	7	9	al	al	PROPN
dpc-4232	7	10	.	.	PUNCT
dpc-4232	8	1	this	this	PRON
dpc-4232	8	2	is	be	AUX
dpc-4232	8	3	an	an	DET
dpc-4232	8	4	open	open	ADJ
dpc-4232	8	5	-	-	PUNCT
dpc-4232	8	6	access	access	NOUN
dpc-4232	8	7	article	article	NOUN
dpc-4232	8	8	distributed	distribute	VERB
dpc-4232	8	9	under	under	ADP
dpc-4232	8	10	the	the	DET
dpc-4232	8	11	terms	term	NOUN
dpc-4232	8	12	of	of	ADP
dpc-4232	8	13	the	the	DET
dpc-4232	8	14	creative	creative	ADJ
dpc-4232	8	15	commons	common	NOUN
dpc-4232	8	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4232	8	17	license	license	NOUN
dpc-4232	8	18	(	(	PUNCT
dpc-4232	8	19	by	by	ADP
dpc-4232	8	20	-	-	PUNCT
dpc-4232	8	21	nc-4.0	nc-4.0	NOUN
dpc-4232	8	22	)	)	PUNCT
dpc-4232	8	23	,	,	PUNCT
dpc-4232	8	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4232	8	25	,	,	PUNCT
dpc-4232	8	26	which	which	PRON
dpc-4232	8	27	permits	permit	VERB
dpc-4232	8	28	unrestricted	unrestricted	ADJ
dpc-4232	8	29	noncommercial	noncommercial	ADJ
dpc-4232	8	30	use	use	NOUN
dpc-4232	8	31	,	,	PUNCT
dpc-4232	8	32	distribution	distribution	NOUN
dpc-4232	8	33	,	,	PUNCT
dpc-4232	8	34	and	and	CCONJ
dpc-4232	8	35	reproduction	reproduction	NOUN
dpc-4232	8	36	in	in	ADP
dpc-4232	8	37	any	any	DET
dpc-4232	8	38	medium	medium	NOUN
dpc-4232	8	39	,	,	PUNCT
dpc-4232	8	40	provided	provide	VERB
dpc-4232	8	41	the	the	DET
dpc-4232	8	42	original	original	ADJ
dpc-4232	8	43	authors	author	NOUN
dpc-4232	8	44	and	and	CCONJ
dpc-4232	8	45	source	source	NOUN
dpc-4232	8	46	are	be	AUX
dpc-4232	8	47	credited	credit	VERB
dpc-4232	8	48	.	.	PUNCT
dpc-4232	9	1	funding	funding	NOUN
dpc-4232	9	2	:	:	PUNCT
dpc-4232	9	3	none	none	NOUN
dpc-4232	9	4	.	.	PUNCT
dpc-4232	10	1	competing	compete	VERB
dpc-4232	10	2	interests	interest	NOUN
dpc-4232	10	3	:	:	PUNCT
dpc-4232	10	4	none	none	NOUN
dpc-4232	10	5	.	.	PUNCT
dpc-4232	11	1	authorship	authorship	NOUN
dpc-4232	11	2	:	:	PUNCT
dpc-4232	11	3	all	all	DET
dpc-4232	11	4	authors	author	NOUN
dpc-4232	11	5	have	have	AUX
dpc-4232	11	6	contributed	contribute	VERB
dpc-4232	11	7	significantly	significantly	ADV
dpc-4232	11	8	to	to	ADP
dpc-4232	11	9	this	this	DET
dpc-4232	11	10	publication	publication	NOUN
dpc-4232	11	11	.	.	PUNCT
dpc-4232	12	1	corresponding	correspond	VERB
dpc-4232	12	2	author	author	NOUN
dpc-4232	12	3	:	:	PUNCT
dpc-4232	12	4	shari	shari	PROPN
dpc-4232	12	5	r.	r.	PROPN
dpc-4232	12	6	lipner	lipner	PROPN
dpc-4232	12	7	md	md	PROPN
dpc-4232	12	8	,	,	PUNCT
dpc-4232	12	9	phd	phd	PROPN
dpc-4232	12	10	,	,	PUNCT
dpc-4232	12	11	1305	1305	PROPN
dpc-4232	12	12	york	york	PROPN
dpc-4232	12	13	avenue	avenue	PROPN
dpc-4232	12	14	,	,	PUNCT
dpc-4232	12	15	9th	9th	ADJ
dpc-4232	12	16	floor	floor	NOUN
dpc-4232	12	17	.	.	PUNCT
dpc-4232	13	1	tel	tel	ADP
dpc-4232	13	2	:	:	PUNCT
dpc-4232	13	3	646	646	NUM
dpc-4232	13	4	-	-	SYM
dpc-4232	13	5	962	962	NUM
dpc-4232	13	6	-	-	PUNCT
dpc-4232	13	7	3376	3376	NUM
dpc-4232	13	8	.	.	PUNCT
dpc-4232	14	1	email	email	NOUN
dpc-4232	14	2	:	:	PUNCT
dpc-4232	14	3	shl9032@med.cornell.edu	shl9032@med.cornell.edu	PROPN
dpc-4232	14	4	introduction	introduction	NOUN
dpc-4232	14	5	localized	localized	ADJ
dpc-4232	14	6	scleroderma	scleroderma	NOUN
dpc-4232	14	7	(	(	PUNCT
dpc-4232	14	8	ls	ls	PROPN
dpc-4232	14	9	)	)	PUNCT
dpc-4232	14	10	,	,	PUNCT
dpc-4232	14	11	including	include	VERB
dpc-4232	14	12	morphea	morphea	NOUN
dpc-4232	14	13	and	and	CCONJ
dpc-4232	14	14	linear	linear	ADJ
dpc-4232	14	15	scleroderma	scleroderma	NOUN
dpc-4232	14	16	,	,	PUNCT
dpc-4232	14	17	is	be	AUX
dpc-4232	14	18	an	an	DET
dpc-4232	14	19	idiopathic	idiopathic	ADJ
dpc-4232	14	20	autoimmune	autoimmune	ADJ
dpc-4232	14	21	pathology	pathology	NOUN
dpc-4232	14	22	characterized	characterize	VERB
dpc-4232	14	23	by	by	ADP
dpc-4232	14	24	fibrosis	fibrosis	NOUN
dpc-4232	14	25	and	and	CCONJ
dpc-4232	14	26	thickening	thickening	NOUN
dpc-4232	14	27	of	of	ADP
dpc-4232	14	28	the	the	DET
dpc-4232	14	29	skin	skin	NOUN
dpc-4232	14	30	and	and	CCONJ
dpc-4232	14	31	underlying	underlying	ADJ
dpc-4232	14	32	tissues	tissue	NOUN
dpc-4232	14	33	.	.	PUNCT
dpc-4232	15	1	[	[	X
dpc-4232	15	2	1,2	1,2	NUM
dpc-4232	15	3	]	]	X
dpc-4232	15	4	ls	ls	X
dpc-4232	15	5	is	be	AUX
dpc-4232	15	6	more	more	ADV
dpc-4232	15	7	common	common	ADJ
dpc-4232	15	8	in	in	ADP
dpc-4232	15	9	females	female	NOUN
dpc-4232	15	10	and	and	CCONJ
dpc-4232	15	11	young	young	ADJ
dpc-4232	15	12	children	child	NOUN
dpc-4232	15	13	,	,	PUNCT
dpc-4232	15	14	and	and	CCONJ
dpc-4232	15	15	while	while	SCONJ
dpc-4232	15	16	prevalence	prevalence	NOUN
dpc-4232	15	17	is	be	AUX
dpc-4232	15	18	similar	similar	ADJ
dpc-4232	15	19	between	between	ADP
dpc-4232	15	20	races	race	NOUN
dpc-4232	15	21	,	,	PUNCT
dpc-4232	15	22	black	black	ADJ
dpc-4232	15	23	vs	vs	ADP
dpc-4232	15	24	white	white	ADJ
dpc-4232	15	25	scleroderma	scleroderma	NOUN
dpc-4232	15	26	patients	patient	NOUN
dpc-4232	15	27	had	have	VERB
dpc-4232	15	28	more	more	ADV
dpc-4232	15	29	severe	severe	ADJ
dpc-4232	15	30	presentations	presentation	NOUN
dpc-4232	15	31	in	in	ADP
dpc-4232	15	32	single	single	ADJ
dpc-4232	15	33	-	-	PUNCT
dpc-4232	15	34	center	center	NOUN
dpc-4232	15	35	studies	study	NOUN
dpc-4232	15	36	.	.	PUNCT
dpc-4232	16	1	[	[	X
dpc-4232	16	2	3	3	NUM
dpc-4232	16	3	]	]	PUNCT
dpc-4232	16	4	therefore	therefore	ADV
dpc-4232	16	5	,	,	PUNCT
dpc-4232	16	6	we	we	PRON
dpc-4232	16	7	aimed	aim	VERB
dpc-4232	16	8	to	to	PART
dpc-4232	16	9	characterize	characterize	VERB
dpc-4232	16	10	associations	association	NOUN
dpc-4232	16	11	in	in	ADP
dpc-4232	16	12	black	black	ADJ
dpc-4232	16	13	ls	ls	ADJ
dpc-4232	16	14	patients	patient	NOUN
dpc-4232	16	15	nationally	nationally	ADV
dpc-4232	16	16	.	.	PUNCT
dpc-4232	17	1	case	case	NOUN
dpc-4232	17	2	presentation	presentation	NOUN
dpc-4232	17	3	the	the	DET
dpc-4232	17	4	2017	2017	NUM
dpc-4232	17	5	national	national	ADJ
dpc-4232	17	6	inpatient	inpatient	PROPN
dpc-4232	17	7	sample	sample	NOUN
dpc-4232	17	8	(	(	PUNCT
dpc-4232	17	9	nis	nis	NOUN
dpc-4232	17	10	)	)	PUNCT
dpc-4232	17	11	was	be	AUX
dpc-4232	17	12	queried	query	VERB
dpc-4232	17	13	for	for	ADP
dpc-4232	17	14	ls	ls	ADJ
dpc-4232	17	15	cases	case	NOUN
dpc-4232	17	16	using	use	VERB
dpc-4232	17	17	these	these	DET
dpc-4232	17	18	icd-10	icd-10	ADJ
dpc-4232	17	19	-	-	PUNCT
dpc-4232	17	20	cm	cm	NOUN
dpc-4232	17	21	codes	code	NOUN
dpc-4232	17	22	:	:	PUNCT
dpc-4232	17	23	l94.0	l94.0	NUM
dpc-4232	17	24	/	/	SYM
dpc-4232	17	25	l94.1	l94.1	PROPN
dpc-4232	17	26	.	.	PUNCT
dpc-4232	18	1	multivariable	multivariable	ADJ
dpc-4232	18	2	logistic	logistic	ADJ
dpc-4232	18	3	and	and	CCONJ
dpc-4232	18	4	linear	linear	ADJ
dpc-4232	18	5	regression	regression	NOUN
dpc-4232	18	6	analyses	analyse	VERB
dpc-4232	18	7	assessed	assess	VERB
dpc-4232	18	8	associations	association	NOUN
dpc-4232	18	9	between	between	ADP
dpc-4232	18	10	the	the	DET
dpc-4232	18	11	black	black	ADJ
dpc-4232	18	12	race	race	NOUN
dpc-4232	18	13	of	of	ADP
dpc-4232	18	14	ls	ls	ADJ
dpc-4232	18	15	patients	patient	NOUN
dpc-4232	18	16	and	and	CCONJ
dpc-4232	18	17	demographic	demographic	ADJ
dpc-4232	18	18	,	,	PUNCT
dpc-4232	18	19	comorbidity	comorbidity	NOUN
dpc-4232	18	20	,	,	PUNCT
dpc-4232	18	21	and	and	CCONJ
dpc-4232	18	22	outcome	outcome	NOUN
dpc-4232	18	23	variables	variable	NOUN
dpc-4232	18	24	(	(	PUNCT
dpc-4232	18	25	p<0.05	p<0.05	PROPN
dpc-4232	18	26	)	)	PUNCT
dpc-4232	18	27	(	(	PUNCT
dpc-4232	18	28	ibm	ibm	PROPN
dpc-4232	18	29	spss	spss	PROPN
dpc-4232	18	30	25	25	NUM
dpc-4232	18	31	)	)	PUNCT
dpc-4232	18	32	.	.	PUNCT
dpc-4232	19	1	there	there	PRON
dpc-4232	19	2	was	be	VERB
dpc-4232	19	3	a	a	DET
dpc-4232	19	4	total	total	NOUN
dpc-4232	19	5	of	of	ADP
dpc-4232	19	6	3,750	3,750	NUM
dpc-4232	19	7	ls	ls	ADJ
dpc-4232	19	8	patients	patient	NOUN
dpc-4232	19	9	,	,	PUNCT
dpc-4232	19	10	63.7	63.7	NUM
dpc-4232	19	11	%	%	NOUN
dpc-4232	19	12	white	white	ADJ
dpc-4232	19	13	and	and	CCONJ
dpc-4232	19	14	16.4	16.4	NUM
dpc-4232	19	15	%	%	NOUN
dpc-4232	19	16	black	black	ADJ
dpc-4232	19	17	.	.	PUNCT
dpc-4232	20	1	black	black	ADJ
dpc-4232	20	2	vs.	vs.	X
dpc-4232	20	3	white	white	ADJ
dpc-4232	20	4	ls	ls	PROPN
dpc-4232	20	5	patients	patient	NOUN
dpc-4232	20	6	were	be	AUX
dpc-4232	20	7	,	,	PUNCT
dpc-4232	20	8	on	on	ADP
dpc-4232	20	9	average	average	ADJ
dpc-4232	20	10	,	,	PUNCT
dpc-4232	20	11	younger	young	ADJ
dpc-4232	20	12	(	(	PUNCT
dpc-4232	20	13	52.78	52.78	NUM
dpc-4232	20	14	[	[	X
dpc-4232	20	15	sd:16.91	sd:16.91	X
dpc-4232	20	16	]	]	X
dpc-4232	20	17	vs.	vs.	ADP
dpc-4232	20	18	58.13	58.13	NUM
dpc-4232	20	19	years	year	NOUN
dpc-4232	20	20	[	[	X
dpc-4232	20	21	sd:18.67	sd:18.67	X
dpc-4232	20	22	]	]	X
dpc-4232	20	23	,	,	PUNCT
dpc-4232	20	24	p<0.001	p<0.001	PROPN
dpc-4232	20	25	)	)	PUNCT
dpc-4232	20	26	.	.	PUNCT
dpc-4232	21	1	female	female	ADJ
dpc-4232	21	2	(	(	PUNCT
dpc-4232	21	3	76.7	76.7	NUM
dpc-4232	21	4	%	%	NOUN
dpc-4232	21	5	)	)	PUNCT
dpc-4232	21	6	vs.	vs.	X
dpc-4232	21	7	male	male	NOUN
dpc-4232	21	8	(	(	PUNCT
dpc-4232	21	9	23.3	23.3	NUM
dpc-4232	21	10	%	%	NOUN
dpc-4232	21	11	)	)	PUNCT
dpc-4232	21	12	ls	ls	ADJ
dpc-4232	21	13	patients	patient	NOUN
dpc-4232	21	14	were	be	AUX
dpc-4232	21	15	more	more	ADV
dpc-4232	21	16	often	often	ADV
dpc-4232	21	17	black	black	ADJ
dpc-4232	21	18	(	(	PUNCT
dpc-4232	21	19	or:1.711	or:1.711	NOUN
dpc-4232	21	20	,	,	PUNCT
dpc-4232	21	21	95	95	NUM
dpc-4232	21	22	%	%	NOUN
dpc-4232	21	23	ci	ci	NOUN
dpc-4232	21	24	:	:	PUNCT
dpc-4232	21	25	1.292–2.265	1.292–2.265	NUM
dpc-4232	21	26	,	,	PUNCT
dpc-4232	21	27	p<0.001	p<0.001	PROPN
dpc-4232	21	28	)	)	PUNCT
dpc-4232	21	29	.	.	PUNCT
dpc-4232	22	1	blacks	black	NOUN
dpc-4232	22	2	more	more	ADV
dpc-4232	22	3	often	often	ADV
dpc-4232	22	4	had	have	VERB
dpc-4232	22	5	the	the	DET
dpc-4232	22	6	most	most	ADV
dpc-4232	22	7	associated	associate	VERB
dpc-4232	22	8	comorbidities	comorbiditie	NOUN
dpc-4232	22	9	,	,	PUNCT
dpc-4232	22	10	including	include	VERB
dpc-4232	22	11	valvular	valvular	ADJ
dpc-4232	22	12	disease	disease	NOUN
dpc-4232	22	13	,	,	PUNCT
dpc-4232	22	14	pulmonary	pulmonary	ADJ
dpc-4232	22	15	circulation	circulation	NOUN
dpc-4232	22	16	disease	disease	NOUN
dpc-4232	22	17	,	,	PUNCT
dpc-4232	22	18	diabetes	diabetes	NOUN
dpc-4232	22	19	mellitus	mellitus	NOUN
dpc-4232	22	20	(	(	PUNCT
dpc-4232	22	21	dm	dm	PROPN
dpc-4232	22	22	)	)	PUNCT
dpc-4232	22	23	,	,	PUNCT
dpc-4232	22	24	hypothyroidism	hypothyroidism	NOUN
dpc-4232	22	25	,	,	PUNCT
dpc-4232	22	26	and	and	CCONJ
dpc-4232	22	27	renal	renal	ADJ
dpc-4232	22	28	failure	failure	NOUN
dpc-4232	22	29	.	.	PUNCT
dpc-4232	23	1	black	black	ADJ
dpc-4232	23	2	vs.	vs.	X
dpc-4232	23	3	white	white	ADJ
dpc-4232	23	4	ls	ls	PROPN
dpc-4232	23	5	patients	patient	NOUN
dpc-4232	23	6	had	have	VERB
dpc-4232	23	7	lower	low	ADJ
dpc-4232	23	8	likelihoods	likelihood	NOUN
dpc-4232	23	9	of	of	ADP
dpc-4232	23	10	liver	liver	NOUN
dpc-4232	23	11	disease	disease	NOUN
dpc-4232	23	12	(	(	PUNCT
dpc-4232	23	13	or	or	CCONJ
dpc-4232	23	14	:	:	PUNCT
dpc-4232	23	15	0.433	0.433	NUM
dpc-4232	23	16	,	,	PUNCT
dpc-4232	23	17	95	95	NUM
dpc-4232	23	18	%	%	NOUN
dpc-4232	23	19	ci	ci	NOUN
dpc-4232	23	20	:	:	PUNCT
dpc-4232	23	21	0.260–0.723	0.260–0.723	PROPN
dpc-4232	23	22	,	,	PUNCT
dpc-4232	23	23	p=0.001	p=0.001	NUM
dpc-4232	23	24	)	)	PUNCT
dpc-4232	23	25	,	,	PUNCT
dpc-4232	23	26	drug	drug	NOUN
dpc-4232	23	27	abuse	abuse	NOUN
dpc-4232	23	28	(	(	PUNCT
dpc-4232	23	29	or	or	CCONJ
dpc-4232	23	30	:	:	PUNCT
dpc-4232	23	31	0.460	0.460	NUM
dpc-4232	23	32	,	,	PUNCT
dpc-4232	23	33	95	95	NUM
dpc-4232	23	34	%	%	NOUN
dpc-4232	23	35	ci	ci	NOUN
dpc-4232	23	36	:	:	PUNCT
dpc-4232	23	37	0.220–0.964	0.220–0.964	ADJ
dpc-4232	23	38	,	,	PUNCT
dpc-4232	23	39	p=0.040	p=0.040	NOUN
dpc-4232	23	40	)	)	PUNCT
dpc-4232	23	41	,	,	PUNCT
dpc-4232	23	42	and	and	CCONJ
dpc-4232	23	43	depression	depression	NOUN
dpc-4232	23	44	(	(	PUNCT
dpc-4232	23	45	or	or	CCONJ
dpc-4232	23	46	:	:	PUNCT
dpc-4232	23	47	0.357	0.357	NUM
dpc-4232	23	48	,	,	PUNCT
dpc-4232	23	49	95	95	NUM
dpc-4232	23	50	%	%	NOUN
dpc-4232	23	51	ci	ci	NOUN
dpc-4232	23	52	:	:	PUNCT
dpc-4232	23	53	0.250–0.508	0.250–0.508	NOUN
dpc-4232	23	54	,	,	PUNCT
dpc-4232	23	55	p<0.001	p<0.001	PROPN
dpc-4232	23	56	)	)	PUNCT
dpc-4232	23	57	.	.	PUNCT
dpc-4232	24	1	black	black	ADJ
dpc-4232	24	2	race	race	NOUN
dpc-4232	24	3	did	do	AUX
dpc-4232	24	4	not	not	PART
dpc-4232	24	5	impact	impact	VERB
dpc-4232	24	6	hypertension	hypertension	NOUN
dpc-4232	24	7	risk	risk	NOUN
dpc-4232	24	8	(	(	PUNCT
dpc-4232	24	9	or	or	CCONJ
dpc-4232	24	10	:	:	PUNCT
dpc-4232	24	11	1.023	1.023	NUM
dpc-4232	24	12	,	,	PUNCT
dpc-4232	24	13	95	95	NUM
dpc-4232	24	14	%	%	NOUN
dpc-4232	24	15	ci	ci	NOUN
dpc-4232	24	16	:	:	PUNCT
dpc-4232	24	17	0.785–1.333	0.785–1.333	NOUN
dpc-4232	24	18	,	,	PUNCT
dpc-4232	24	19	p=0.869	p=0.869	NOUN
dpc-4232	24	20	)	)	PUNCT
dpc-4232	24	21	(	(	PUNCT
dpc-4232	24	22	table	table	NOUN
dpc-4232	24	23	1	1	NUM
dpc-4232	24	24	)	)	PUNCT
dpc-4232	24	25	.	.	PUNCT
dpc-4232	25	1	2	2	NUM
dpc-4232	25	2	research	research	NOUN
dpc-4232	25	3	letter	letter	NOUN
dpc-4232	25	4	|	|	ADV
dpc-4232	25	5	dermatol	dermatol	ADJ
dpc-4232	25	6	pract	pract	NOUN
dpc-4232	25	7	concept	concept	NOUN
dpc-4232	25	8	.	.	PUNCT
dpc-4232	26	1	2024;14(4):e2024224	2024;14(4):e2024224	NUM
dpc-4232	26	2	black	black	ADJ
dpc-4232	26	3	patients	patient	NOUN
dpc-4232	26	4	had	have	AUX
dpc-4232	26	5	increased	increase	VERB
dpc-4232	26	6	lengths	length	NOUN
dpc-4232	26	7	of	of	ADP
dpc-4232	26	8	stay	stay	NOUN
dpc-4232	26	9	(	(	PUNCT
dpc-4232	26	10	los	los	PROPN
dpc-4232	26	11	)	)	PUNCT
dpc-4232	26	12	of	of	ADP
dpc-4232	26	13	1.012	1.012	NUM
dpc-4232	26	14	days	day	NOUN
dpc-4232	26	15	(	(	PUNCT
dpc-4232	26	16	95	95	NUM
dpc-4232	26	17	%	%	NOUN
dpc-4232	26	18	ci	ci	NOUN
dpc-4232	26	19	:	:	PUNCT
dpc-4232	26	20	0.080–1.944	0.080–1.944	NOUN
dpc-4232	26	21	,	,	PUNCT
dpc-4232	26	22	p=0.033	p=0.033	NOUN
dpc-4232	26	23	)	)	PUNCT
dpc-4232	26	24	and	and	CCONJ
dpc-4232	26	25	fewer	few	ADJ
dpc-4232	26	26	average	average	ADJ
dpc-4232	26	27	number	number	NOUN
dpc-4232	26	28	of	of	ADP
dpc-4232	26	29	procedures	procedure	NOUN
dpc-4232	26	30	performed	perform	VERB
dpc-4232	26	31	(	(	PUNCT
dpc-4232	26	32	marginal	marginal	ADJ
dpc-4232	26	33	difference	difference	NOUN
dpc-4232	26	34	-0.289	-0.289	NOUN
dpc-4232	26	35	,	,	PUNCT
dpc-4232	26	36	95	95	NUM
dpc-4232	26	37	%	%	NOUN
dpc-4232	26	38	ci	ci	NOUN
dpc-4232	26	39	:	:	PUNCT
dpc-4232	26	40	-0.542–0.037	-0.542–0.037	PROPN
dpc-4232	26	41	,	,	PUNCT
dpc-4232	26	42	p=0.025	p=0.025	NOUN
dpc-4232	26	43	)	)	PUNCT
dpc-4232	26	44	than	than	ADP
dpc-4232	26	45	white	white	ADJ
dpc-4232	26	46	patients	patient	NOUN
dpc-4232	26	47	.	.	PUNCT
dpc-4232	27	1	increased	increase	VERB
dpc-4232	27	2	los	los	PROPN
dpc-4232	27	3	might	might	AUX
dpc-4232	27	4	reflect	reflect	VERB
dpc-4232	27	5	their	their	PRON
dpc-4232	27	6	previously	previously	ADV
dpc-4232	27	7	reported	report	VERB
dpc-4232	27	8	poorer	poor	ADJ
dpc-4232	27	9	outcomes	outcome	NOUN
dpc-4232	27	10	(	(	PUNCT
dpc-4232	27	11	at	at	ADP
dpc-4232	27	12	least	least	ADJ
dpc-4232	27	13	for	for	ADP
dpc-4232	27	14	systemic	systemic	ADJ
dpc-4232	27	15	scleroderma	scleroderma	NOUN
dpc-4232	27	16	)	)	PUNCT
dpc-4232	27	17	due	due	ADP
dpc-4232	27	18	to	to	ADP
dpc-4232	27	19	racial	racial	ADJ
dpc-4232	27	20	disparities	disparity	NOUN
dpc-4232	27	21	and	and	CCONJ
dpc-4232	27	22	disease	disease	NOUN
dpc-4232	27	23	pathogenesis	pathogenesis	NOUN
dpc-4232	27	24	.	.	PUNCT
dpc-4232	28	1	in	in	ADP
dpc-4232	28	2	a	a	DET
dpc-4232	28	3	retrospective	retrospective	ADJ
dpc-4232	28	4	study	study	NOUN
dpc-4232	28	5	of	of	ADP
dpc-4232	28	6	2,217	2,217	NUM
dpc-4232	28	7	systemic	systemic	ADJ
dpc-4232	28	8	scleroderma	scleroderma	NOUN
dpc-4232	28	9	patients	patient	NOUN
dpc-4232	28	10	,	,	PUNCT
dpc-4232	28	11	blacks	black	NOUN
dpc-4232	28	12	had	have	AUX
dpc-4232	28	13	increased	increase	VERB
dpc-4232	28	14	odds	odd	NOUN
dpc-4232	28	15	of	of	ADP
dpc-4232	28	16	cardiac	cardiac	ADJ
dpc-4232	28	17	(	(	PUNCT
dpc-4232	28	18	or	or	CCONJ
dpc-4232	28	19	:	:	PUNCT
dpc-4232	28	20	1.6	1.6	NUM
dpc-4232	28	21	)	)	PUNCT
dpc-4232	28	22	,	,	PUNCT
dpc-4232	28	23	renal	renal	ADJ
dpc-4232	28	24	(	(	PUNCT
dpc-4232	28	25	or	or	CCONJ
dpc-4232	28	26	:	:	PUNCT
dpc-4232	28	27	1.6	1.6	NUM
dpc-4232	28	28	)	)	PUNCT
dpc-4232	28	29	and	and	CCONJ
dpc-4232	28	30	muscle	muscle	NOUN
dpc-4232	28	31	diseases	disease	NOUN
dpc-4232	28	32	(	(	PUNCT
dpc-4232	28	33	or	or	CCONJ
dpc-4232	28	34	:	:	PUNCT
dpc-4232	28	35	1.7	1.7	NUM
dpc-4232	28	36	)	)	PUNCT
dpc-4232	28	37	,	,	PUNCT
dpc-4232	28	38	and	and	CCONJ
dpc-4232	28	39	mortality	mortality	NOUN
dpc-4232	28	40	(	(	PUNCT
dpc-4232	28	41	43	43	NUM
dpc-4232	28	42	%	%	NOUN
dpc-4232	28	43	vs.	vs.	ADP
dpc-4232	28	44	35	35	NUM
dpc-4232	28	45	%	%	NOUN
dpc-4232	28	46	,	,	PUNCT
dpc-4232	28	47	p=0.001	p=0.001	NUM
dpc-4232	28	48	)	)	PUNCT
dpc-4232	28	49	.	.	PUNCT
dpc-4232	29	1	[	[	X
dpc-4232	29	2	3	3	NUM
dpc-4232	29	3	]	]	PUNCT
dpc-4232	29	4	therefore	therefore	ADV
dpc-4232	29	5	,	,	PUNCT
dpc-4232	29	6	our	our	PRON
dpc-4232	29	7	finding	find	VERB
dpc-4232	29	8	that	that	SCONJ
dpc-4232	29	9	black	black	ADJ
dpc-4232	29	10	patients	patient	NOUN
dpc-4232	29	11	more	more	ADV
dpc-4232	29	12	often	often	ADV
dpc-4232	29	13	had	have	VERB
dpc-4232	29	14	comorbid	comorbid	NOUN
dpc-4232	29	15	conditions	condition	NOUN
dpc-4232	29	16	might	might	AUX
dpc-4232	29	17	indirectly	indirectly	ADV
dpc-4232	29	18	explain	explain	VERB
dpc-4232	29	19	the	the	DET
dpc-4232	29	20	increased	increase	VERB
dpc-4232	29	21	los	los	NOUN
dpc-4232	29	22	in	in	ADP
dpc-4232	29	23	blacks	black	NOUN
dpc-4232	29	24	via	via	ADP
dpc-4232	29	25	increased	increase	VERB
dpc-4232	29	26	disease	disease	NOUN
dpc-4232	29	27	severity	severity	NOUN
dpc-4232	29	28	,	,	PUNCT
dpc-4232	29	29	but	but	CCONJ
dpc-4232	29	30	this	this	PRON
dpc-4232	29	31	could	could	AUX
dpc-4232	29	32	also	also	ADV
dpc-4232	29	33	be	be	AUX
dpc-4232	29	34	due	due	ADJ
dpc-4232	29	35	to	to	ADP
dpc-4232	29	36	other	other	ADJ
dpc-4232	29	37	causes	cause	NOUN
dpc-4232	29	38	,	,	PUNCT
dpc-4232	29	39	including	include	VERB
dpc-4232	29	40	economic	economic	ADJ
dpc-4232	29	41	disparities	disparity	NOUN
dpc-4232	29	42	,	,	PUNCT
dpc-4232	29	43	mistrust	mistrust	NOUN
dpc-4232	29	44	and	and	CCONJ
dpc-4232	29	45	communication	communication	NOUN
dpc-4232	29	46	barriers	barrier	NOUN
dpc-4232	29	47	,	,	PUNCT
dpc-4232	29	48	and	and	CCONJ
dpc-4232	29	49	less	less	ADV
dpc-4232	29	50	social	social	ADJ
dpc-4232	29	51	support	support	NOUN
dpc-4232	29	52	versus	versus	ADP
dpc-4232	29	53	other	other	ADJ
dpc-4232	29	54	groups	group	NOUN
dpc-4232	29	55	.	.	PUNCT
dpc-4232	30	1	conversely	conversely	ADV
dpc-4232	30	2	,	,	PUNCT
dpc-4232	30	3	the	the	DET
dpc-4232	30	4	lower	low	ADJ
dpc-4232	30	5	likelihood	likelihood	NOUN
dpc-4232	30	6	of	of	ADP
dpc-4232	30	7	liver	liver	NOUN
dpc-4232	30	8	disease	disease	NOUN
dpc-4232	30	9	in	in	ADP
dpc-4232	30	10	black	black	ADJ
dpc-4232	30	11	ls	ls	ADJ
dpc-4232	30	12	patients	patient	NOUN
dpc-4232	30	13	might	might	AUX
dpc-4232	30	14	be	be	AUX
dpc-4232	30	15	explained	explain	VERB
dpc-4232	30	16	by	by	ADP
dpc-4232	30	17	the	the	DET
dpc-4232	30	18	commonality	commonality	NOUN
dpc-4232	30	19	of	of	ADP
dpc-4232	30	20	primary	primary	ADJ
dpc-4232	30	21	biliary	biliary	NOUN
dpc-4232	30	22	cholangitis	cholangitis	NOUN
dpc-4232	30	23	(	(	PUNCT
dpc-4232	30	24	pbc	pbc	PROPN
dpc-4232	30	25	)	)	PUNCT
dpc-4232	30	26	as	as	ADP
dpc-4232	30	27	a	a	DET
dpc-4232	30	28	liver	liver	NOUN
dpc-4232	30	29	disease	disease	NOUN
dpc-4232	30	30	subtype	subtype	NOUN
dpc-4232	30	31	in	in	ADP
dpc-4232	30	32	ls	ls	ADJ
dpc-4232	30	33	patients	patient	NOUN
dpc-4232	30	34	,	,	PUNCT
dpc-4232	30	35	with	with	ADP
dpc-4232	30	36	pbc	pbc	PROPN
dpc-4232	30	37	being	be	AUX
dpc-4232	30	38	more	more	ADV
dpc-4232	30	39	common	common	ADJ
dpc-4232	30	40	in	in	ADP
dpc-4232	30	41	whites	white	NOUN
dpc-4232	30	42	.	.	PUNCT
dpc-4232	31	1	[	[	X
dpc-4232	31	2	4	4	NUM
dpc-4232	31	3	]	]	PUNCT
dpc-4232	31	4	hypertension	hypertension	NOUN
dpc-4232	31	5	risk	risk	NOUN
dpc-4232	31	6	did	do	AUX
dpc-4232	31	7	not	not	PART
dpc-4232	31	8	vary	vary	VERB
dpc-4232	31	9	between	between	ADP
dpc-4232	31	10	racial	racial	ADJ
dpc-4232	31	11	groups	group	NOUN
dpc-4232	31	12	.	.	PUNCT
dpc-4232	32	1	this	this	PRON
dpc-4232	32	2	may	may	AUX
dpc-4232	32	3	be	be	AUX
dpc-4232	32	4	due	due	ADJ
dpc-4232	32	5	to	to	ADP
dpc-4232	32	6	the	the	DET
dpc-4232	32	7	pathological	pathological	ADJ
dpc-4232	32	8	association	association	NOUN
dpc-4232	32	9	of	of	ADP
dpc-4232	32	10	pulmonary	pulmonary	ADJ
dpc-4232	32	11	arterial	arterial	ADJ
dpc-4232	32	12	hypertension	hypertension	NOUN
dpc-4232	32	13	(	(	PUNCT
dpc-4232	32	14	and	and	CCONJ
dpc-4232	32	15	subsequent	subsequent	ADJ
dpc-4232	32	16	secondary	secondary	ADJ
dpc-4232	32	17	hypertension	hypertension	NOUN
dpc-4232	32	18	)	)	PUNCT
dpc-4232	32	19	with	with	ADP
dpc-4232	32	20	scleroderma	scleroderma	NOUN
dpc-4232	32	21	regardless	regardless	ADV
dpc-4232	32	22	of	of	ADP
dpc-4232	32	23	race	race	NOUN
dpc-4232	32	24	,	,	PUNCT
dpc-4232	32	25	thus	thus	ADV
dpc-4232	32	26	minimizing	minimize	VERB
dpc-4232	32	27	any	any	DET
dpc-4232	32	28	racial	racial	ADJ
dpc-4232	32	29	association	association	NOUN
dpc-4232	32	30	with	with	ADP
dpc-4232	32	31	hypertension	hypertension	NOUN
dpc-4232	32	32	that	that	PRON
dpc-4232	32	33	might	might	AUX
dpc-4232	32	34	otherwise	otherwise	ADV
dpc-4232	32	35	be	be	AUX
dpc-4232	32	36	seen	see	VERB
dpc-4232	32	37	in	in	ADP
dpc-4232	32	38	the	the	DET
dpc-4232	32	39	general	general	ADJ
dpc-4232	32	40	population	population	NOUN
dpc-4232	32	41	.	.	PUNCT
dpc-4232	33	1	[	[	X
dpc-4232	33	2	5	5	NUM
dpc-4232	33	3	]	]	SYM
dpc-4232	33	4	limitations	limitation	NOUN
dpc-4232	33	5	of	of	ADP
dpc-4232	33	6	this	this	DET
dpc-4232	33	7	study	study	NOUN
dpc-4232	33	8	include	include	VERB
dpc-4232	33	9	its	its	PRON
dpc-4232	33	10	retrospective	retrospective	ADJ
dpc-4232	33	11	nature	nature	NOUN
dpc-4232	33	12	and	and	CCONJ
dpc-4232	33	13	the	the	DET
dpc-4232	33	14	recording	recording	NOUN
dpc-4232	33	15	of	of	ADP
dpc-4232	33	16	scleroderma	scleroderma	NOUN
dpc-4232	33	17	-	-	PUNCT
dpc-4232	33	18	specific	specific	ADJ
dpc-4232	33	19	symptoms	symptom	NOUN
dpc-4232	33	20	.	.	PUNCT
dpc-4232	34	1	strengths	strength	NOUN
dpc-4232	34	2	include	include	VERB
dpc-4232	34	3	national	national	ADJ
dpc-4232	34	4	breadth	breadth	NOUN
dpc-4232	34	5	and	and	CCONJ
dpc-4232	34	6	large	large	ADJ
dpc-4232	34	7	sample	sample	NOUN
dpc-4232	34	8	size	size	NOUN
dpc-4232	34	9	.	.	PUNCT
dpc-4232	35	1	conclusion	conclusion	NOUN
dpc-4232	35	2	in	in	ADP
dpc-4232	35	3	sum	sum	NOUN
dpc-4232	35	4	,	,	PUNCT
dpc-4232	35	5	black	black	ADJ
dpc-4232	35	6	vs.	vs.	X
dpc-4232	35	7	white	white	ADJ
dpc-4232	35	8	ls	ls	ADJ
dpc-4232	35	9	patients	patient	NOUN
dpc-4232	35	10	are	be	AUX
dpc-4232	35	11	less	less	ADV
dpc-4232	35	12	likely	likely	ADJ
dpc-4232	35	13	to	to	PART
dpc-4232	35	14	have	have	VERB
dpc-4232	35	15	liver	liver	NOUN
dpc-4232	35	16	disease	disease	NOUN
dpc-4232	35	17	and	and	CCONJ
dpc-4232	35	18	inpatient	inpatient	NOUN
dpc-4232	35	19	procedures	procedure	NOUN
dpc-4232	35	20	,	,	PUNCT
dpc-4232	35	21	but	but	CCONJ
dpc-4232	35	22	higher	high	ADJ
dpc-4232	35	23	los	los	NOUN
dpc-4232	35	24	and	and	CCONJ
dpc-4232	35	25	risk	risk	NOUN
dpc-4232	35	26	of	of	ADP
dpc-4232	35	27	dm	dm	NOUN
dpc-4232	35	28	,	,	PUNCT
dpc-4232	35	29	hypothyroidism	hypothyroidism	NOUN
dpc-4232	35	30	,	,	PUNCT
dpc-4232	35	31	and	and	CCONJ
dpc-4232	35	32	renal	renal	ADJ
dpc-4232	35	33	disease	disease	NOUN
dpc-4232	35	34	.	.	PUNCT
dpc-4232	36	1	dermatologists	dermatologist	NOUN
dpc-4232	36	2	might	might	AUX
dpc-4232	36	3	keep	keep	VERB
dpc-4232	36	4	such	such	ADJ
dpc-4232	36	5	associations	association	NOUN
dpc-4232	36	6	in	in	ADP
dpc-4232	36	7	mind	mind	NOUN
dpc-4232	36	8	when	when	SCONJ
dpc-4232	36	9	treating	treat	VERB
dpc-4232	36	10	ls	ls	ADJ
dpc-4232	36	11	patients	patient	NOUN
dpc-4232	36	12	,	,	PUNCT
dpc-4232	36	13	to	to	PART
dpc-4232	36	14	optimize	optimize	VERB
dpc-4232	36	15	care	care	NOUN
dpc-4232	36	16	and	and	CCONJ
dpc-4232	36	17	strive	strive	VERB
dpc-4232	36	18	toward	toward	ADP
dpc-4232	36	19	equitable	equitable	ADJ
dpc-4232	36	20	outcomes	outcome	NOUN
dpc-4232	36	21	.	.	PUNCT
dpc-4232	37	1	references	reference	NOUN
dpc-4232	37	2	1	1	NUM
dpc-4232	37	3	.	.	PUNCT
dpc-4232	37	4	kreuter	kreuter	NOUN
dpc-4232	37	5	a.	a.	NOUN
dpc-4232	37	6	localized	localize	VERB
dpc-4232	37	7	scleroderma	scleroderma	NOUN
dpc-4232	37	8	.	.	PUNCT
dpc-4232	37	9	  	  	SPACE
dpc-4232	38	1	dermatol	dermatol	NOUN
dpc-4232	38	2	ther	ther	ADV
dpc-4232	38	3	.	.	PUNCT
dpc-4232	39	1	2012	2012	NUM
dpc-4232	39	2	;	;	PUNCT
dpc-4232	39	3	25(2):135	25(2):135	NOUN
dpc-4232	39	4	-	-	SYM
dpc-4232	39	5	147	147	NUM
dpc-4232	39	6	.	.	PUNCT
dpc-4232	40	1	doi:10.1111	doi:10.1111	PROPN
dpc-4232	40	2	/	/	SYM
dpc-4232	40	3	j.1529	j.1529	NOUN
dpc-4232	40	4	-	-	PUNCT
dpc-4232	40	5	8019.2012.01479.x	8019.2012.01479.x	NUM
dpc-4232	40	6	2	2	NUM
dpc-4232	40	7	.	.	PUNCT
dpc-4232	40	8	careta	careta	PROPN
dpc-4232	40	9	mf	mf	PROPN
dpc-4232	40	10	,	,	PUNCT
dpc-4232	40	11	romiti	romiti	PROPN
dpc-4232	40	12	r.	r.	PROPN
dpc-4232	40	13	localized	localize	VERB
dpc-4232	40	14	scleroderma	scleroderma	NOUN
dpc-4232	40	15	:	:	PUNCT
dpc-4232	40	16	clinical	clinical	ADJ
dpc-4232	40	17	spectrum	spectrum	NOUN
dpc-4232	40	18	and	and	CCONJ
dpc-4232	40	19	therapeutic	therapeutic	ADJ
dpc-4232	40	20	update	update	NOUN
dpc-4232	40	21	.	.	PUNCT
dpc-4232	40	22	  	  	SPACE
dpc-4232	41	1	an	an	DET
dpc-4232	41	2	bras	bras	NOUN
dpc-4232	41	3	dermatol	dermatol	NOUN
dpc-4232	41	4	.	.	PUNCT
dpc-4232	42	1	2015;90(1):62	2015;90(1):62	NUM
dpc-4232	42	2	-	-	SYM
dpc-4232	42	3	73	73	NUM
dpc-4232	42	4	.	.	PUNCT
dpc-4232	43	1	doi:10.1590	doi:10.1590	ADJ
dpc-4232	43	2	/	/	SYM
dpc-4232	43	3	abd1806	abd1806	ADJ
dpc-4232	43	4	-	-	PUNCT
dpc-4232	43	5	4841.20152890	4841.20152890	NOUN
dpc-4232	43	6	table	table	NOUN
dpc-4232	43	7	1	1	NUM
dpc-4232	43	8	.	.	PUNCT
dpc-4232	43	9	multivariable	multivariable	ADJ
dpc-4232	43	10	adjusted	adjust	VERB
dpc-4232	43	11	odds	odd	NOUN
dpc-4232	43	12	of	of	ADP
dpc-4232	43	13	black	black	ADJ
dpc-4232	43	14	vs	vs	ADP
dpc-4232	43	15	white	white	ADJ
dpc-4232	43	16	race	race	NOUN
dpc-4232	43	17	on	on	ADP
dpc-4232	43	18	various	various	ADJ
dpc-4232	43	19	comorbidities	comorbiditie	NOUN
dpc-4232	43	20	in	in	ADP
dpc-4232	43	21	 	 	SPACE
dpc-4232	43	22	cutaneous	cutaneous	ADJ
dpc-4232	43	23	scleroderma	scleroderma	NOUN
dpc-4232	43	24	patients	patient	NOUN
dpc-4232	43	25	.	.	PUNCT
dpc-4232	44	1	comorbidities	comorbiditie	NOUN
dpc-4232	44	2	adjusted	adjust	VERB
dpc-4232	44	3	odds	odd	NOUN
dpc-4232	44	4	ratio	ratio	NOUN
dpc-4232	44	5	95	95	NUM
dpc-4232	44	6	%	%	NOUN
dpc-4232	44	7	confidence	confidence	NOUN
dpc-4232	44	8	interval	interval	NOUN
dpc-4232	44	9	p	p	NOUN
dpc-4232	44	10	congestive	congestive	ADJ
dpc-4232	44	11	heart	heart	NOUN
dpc-4232	44	12	failure	failure	NOUN
dpc-4232	44	13	0.836	0.836	NUM
dpc-4232	44	14	0.613	0.613	NUM
dpc-4232	44	15	1.141	1.141	NUM
dpc-4232	44	16	0.259	0.259	NUM
dpc-4232	44	17	valvular	valvular	ADJ
dpc-4232	44	18	disease	disease	NOUN
dpc-4232	44	19	1.623	1.623	NUM
dpc-4232	44	20	1.132	1.132	NUM
dpc-4232	44	21	2.328	2.328	NUM
dpc-4232	44	22	0.008	0.008	NUM
dpc-4232	44	23	pulmonary	pulmonary	ADJ
dpc-4232	44	24	circulation	circulation	NOUN
dpc-4232	44	25	disease	disease	NOUN
dpc-4232	44	26	19.469	19.469	NUM
dpc-4232	44	27	8.033	8.033	NUM
dpc-4232	44	28	47.187	47.187	NUM
dpc-4232	44	29	<	<	NOUN
dpc-4232	44	30	0.001	0.001	NUM
dpc-4232	44	31	peripheral	peripheral	ADJ
dpc-4232	44	32	vascular	vascular	ADJ
dpc-4232	44	33	disease	disease	NOUN
dpc-4232	44	34	0.886	0.886	NUM
dpc-4232	44	35	0.617	0.617	NUM
dpc-4232	44	36	1.274	1.274	NUM
dpc-4232	44	37	0.514	0.514	NUM
dpc-4232	44	38	paralysis	paralysis	NOUN
dpc-4232	44	39	5.303	5.303	NUM
dpc-4232	44	40	2.634	2.634	NUM
dpc-4232	44	41	10.679	10.679	NUM
dpc-4232	44	42	<	<	NOUN
dpc-4232	44	43	0.001	0.001	NUM
dpc-4232	44	44	chronic	chronic	ADJ
dpc-4232	44	45	pulmonary	pulmonary	ADJ
dpc-4232	44	46	disease	disease	NOUN
dpc-4232	44	47	0.812	0.812	NUM
dpc-4232	44	48	0.612	0.612	NUM
dpc-4232	44	49	1.077	1.077	NUM
dpc-4232	44	50	0.148	0.148	NUM
dpc-4232	44	51	diabetes	diabete	NOUN
dpc-4232	44	52	without	without	ADP
dpc-4232	44	53	chronic	chronic	ADJ
dpc-4232	44	54	complications	complication	NOUN
dpc-4232	44	55	1.729	1.729	NUM
dpc-4232	44	56	1.061	1.061	NUM
dpc-4232	44	57	2.816	2.816	NUM
dpc-4232	44	58	0.028	0.028	NUM
dpc-4232	44	59	diabetes	diabete	NOUN
dpc-4232	44	60	with	with	ADP
dpc-4232	44	61	chronic	chronic	ADJ
dpc-4232	44	62	complications	complication	NOUN
dpc-4232	44	63	2.025	2.025	NUM
dpc-4232	44	64	1.46	1.46	NUM
dpc-4232	44	65	2.81	2.81	NUM
dpc-4232	44	66	<	<	NOUN
dpc-4232	44	67	0.001	0.001	NUM
dpc-4232	44	68	hypothyroidism	hypothyroidism	NOUN
dpc-4232	44	69	0.327	0.327	NUM
dpc-4232	44	70	0.232	0.232	NUM
dpc-4232	44	71	0.462	0.462	NUM
dpc-4232	44	72	<	<	NOUN
dpc-4232	44	73	0.001	0.001	NUM
dpc-4232	44	74	renal	renal	ADJ
dpc-4232	44	75	failure	failure	NOUN
dpc-4232	44	76	1.912	1.912	NUM
dpc-4232	44	77	1.385	1.385	NUM
dpc-4232	44	78	2.638	2.638	NUM
dpc-4232	44	79	<	<	NOUN
dpc-4232	44	80	0.001	0.001	NUM
dpc-4232	44	81	liver	liver	NOUN
dpc-4232	44	82	disease	disease	NOUN
dpc-4232	44	83	0.433	0.433	NUM
dpc-4232	44	84	0.26	0.26	NUM
dpc-4232	44	85	0.723	0.723	NUM
dpc-4232	44	86	0.001	0.001	NUM
dpc-4232	44	87	peptic	peptic	ADJ
dpc-4232	44	88	ulcer	ulcer	NOUN
dpc-4232	44	89	disease	disease	NOUN
dpc-4232	44	90	x	x	PUNCT
dpc-4232	44	91	bleeding	bleed	VERB
dpc-4232	44	92	1.030	1.030	NUM
dpc-4232	44	93	0.393	0.393	NUM
dpc-4232	44	94	2.696	2.696	NUM
dpc-4232	44	95	0.953	0.953	NUM
dpc-4232	44	96	lymphoma	lymphoma	VERB
dpc-4232	44	97	2.644	2.644	NUM
dpc-4232	44	98	0.696	0.696	NUM
dpc-4232	44	99	10.041	10.041	NUM
dpc-4232	44	100	0.153	0.153	NUM
dpc-4232	44	101	solid	solid	ADJ
dpc-4232	44	102	tumor	tumor	NOUN
dpc-4232	44	103	(	(	PUNCT
dpc-4232	44	104	no	no	DET
dpc-4232	44	105	metastasis	metastasis	NOUN
dpc-4232	44	106	)	)	PUNCT
dpc-4232	44	107	3.126	3.126	NUM
dpc-4232	44	108	1.518	1.518	NUM
dpc-4232	44	109	6.441	6.441	NUM
dpc-4232	44	110	0.002	0.002	NUM
dpc-4232	44	111	rheumatoid	rheumatoid	VERB
dpc-4232	44	112	arthritis	arthritis	NOUN
dpc-4232	44	113	1.317	1.317	NUM
dpc-4232	44	114	1.019	1.019	NUM
dpc-4232	44	115	1.703	1.703	NUM
dpc-4232	44	116	0.035	0.035	NUM
dpc-4232	44	117	coagulopathy	coagulopathy	ADJ
dpc-4232	44	118	0.864	0.864	NUM
dpc-4232	44	119	0.565	0.565	NUM
dpc-4232	44	120	1.323	1.323	NUM
dpc-4232	44	121	0.502	0.502	NUM
dpc-4232	44	122	obesity	obesity	NOUN
dpc-4232	44	123	0.923	0.923	NUM
dpc-4232	44	124	0.696	0.696	NUM
dpc-4232	44	125	1.222	1.222	NUM
dpc-4232	44	126	0.574	0.574	NUM
dpc-4232	44	127	fluid	fluid	ADJ
dpc-4232	44	128	and	and	CCONJ
dpc-4232	44	129	electrolyte	electrolyte	ADJ
dpc-4232	44	130	disorders	disorder	NOUN
dpc-4232	44	131	0.910	0.910	NUM
dpc-4232	44	132	0.7	0.7	NUM
dpc-4232	44	133	1.183	1.183	NUM
dpc-4232	44	134	0.482	0.482	NUM
dpc-4232	44	135	alcohol	alcohol	NOUN
dpc-4232	44	136	abuse	abuse	NOUN
dpc-4232	44	137	0.868	0.868	NUM
dpc-4232	44	138	0.3	0.3	NUM
dpc-4232	44	139	2.517	2.517	NUM
dpc-4232	44	140	0.795	0.795	NUM
dpc-4232	44	141	drug	drug	NOUN
dpc-4232	44	142	abuse	abuse	NOUN
dpc-4232	44	143	0.460	0.460	NUM
dpc-4232	44	144	0.22	0.22	NUM
dpc-4232	44	145	0.964	0.964	NUM
dpc-4232	44	146	0.040	0.040	NUM
dpc-4232	44	147	depression	depression	NOUN
dpc-4232	44	148	0.357	0.357	NUM
dpc-4232	44	149	0.25	0.25	NUM
dpc-4232	44	150	0.508	0.508	NUM
dpc-4232	44	151	<	<	NOUN
dpc-4232	44	152	0.001	0.001	NUM
dpc-4232	44	153	hypertension	hypertension	NOUN
dpc-4232	44	154	1.023	1.023	NUM
dpc-4232	44	155	0.785	0.785	NUM
dpc-4232	44	156	1.333	1.333	NUM
dpc-4232	44	157	0.869	0.869	NUM
dpc-4232	44	158	research	research	NOUN
dpc-4232	44	159	letter	letter	NOUN
dpc-4232	45	1	|	|	ADV
dpc-4232	45	2	dermatol	dermatol	ADJ
dpc-4232	45	3	pract	pract	NOUN
dpc-4232	45	4	concept	concept	NOUN
dpc-4232	45	5	.	.	PUNCT
dpc-4232	46	1	2024;14(4):e2024224	2024;14(4):e2024224	NUM
dpc-4232	46	2	3	3	NUM
dpc-4232	46	3	3	3	NUM
dpc-4232	46	4	.	.	PUNCT
dpc-4232	46	5	gelber	gelber	PROPN
dpc-4232	46	6	ac	ac	PROPN
dpc-4232	46	7	,	,	PUNCT
dpc-4232	46	8	manno	manno	PROPN
dpc-4232	46	9	rl	rl	PROPN
dpc-4232	46	10	,	,	PUNCT
dpc-4232	46	11	shah	shah	PROPN
dpc-4232	46	12	aa	aa	PROPN
dpc-4232	46	13	,	,	PUNCT
dpc-4232	46	14	et	et	PROPN
dpc-4232	46	15	al	al	PROPN
dpc-4232	46	16	.	.	PUNCT
dpc-4232	46	17	race	race	NOUN
dpc-4232	46	18	and	and	CCONJ
dpc-4232	46	19	association	association	NOUN
dpc-4232	46	20	with	with	ADP
dpc-4232	46	21	disease	disease	NOUN
dpc-4232	46	22	manifestations	manifestation	NOUN
dpc-4232	46	23	and	and	CCONJ
dpc-4232	46	24	mortality	mortality	NOUN
dpc-4232	46	25	in	in	ADP
dpc-4232	46	26	scleroderma	scleroderma	NOUN
dpc-4232	46	27	:	:	PUNCT
dpc-4232	46	28	a	a	DET
dpc-4232	46	29	20	20	NUM
dpc-4232	46	30	-	-	PUNCT
dpc-4232	46	31	year	year	NOUN
dpc-4232	46	32	experience	experience	NOUN
dpc-4232	46	33	at	at	ADP
dpc-4232	46	34	the	the	DET
dpc-4232	46	35	johns	johns	PROPN
dpc-4232	46	36	hopkins	hopkins	PROPN
dpc-4232	46	37	scleroderma	scleroderma	PROPN
dpc-4232	46	38	center	center	PROPN
dpc-4232	46	39	and	and	CCONJ
dpc-4232	46	40	review	review	NOUN
dpc-4232	46	41	of	of	ADP
dpc-4232	46	42	the	the	DET
dpc-4232	46	43	literature	literature	NOUN
dpc-4232	46	44	.	.	PUNCT
dpc-4232	46	45	 	 	SPACE
dpc-4232	47	1	medicine	medicine	NOUN
dpc-4232	47	2	(	(	PUNCT
dpc-4232	47	3	baltimore	baltimore	PROPN
dpc-4232	47	4	)	)	PUNCT
dpc-4232	47	5	.	.	PUNCT
dpc-4232	48	1	2013;92(4	2013;92(4	NUM
dpc-4232	48	2	):	):	PUNCT
dpc-4232	48	3	191	191	NUM
dpc-4232	48	4	-	-	SYM
dpc-4232	48	5	205	205	NUM
dpc-4232	48	6	.	.	PUNCT
dpc-4232	49	1	doi:10.1097	doi:10.1097	NOUN
dpc-4232	49	2	/	/	SYM
dpc-4232	50	1	md.0b013e31829be125	md.0b013e31829be125	ADJ
dpc-4232	50	2	4	4	NUM
dpc-4232	50	3	.	.	PUNCT
dpc-4232	51	1	rigamonti	rigamonti	PROPN
dpc-4232	51	2	c	c	PROPN
dpc-4232	51	3	,	,	PUNCT
dpc-4232	51	4	bogdanos	bogdanos	PROPN
dpc-4232	51	5	dp	dp	PROPN
dpc-4232	51	6	,	,	PUNCT
dpc-4232	51	7	mytilinaiou	mytilinaiou	VERB
dpc-4232	51	8	mg	mg	PROPN
dpc-4232	51	9	,	,	PUNCT
dpc-4232	51	10	smyk	smyk	NOUN
dpc-4232	51	11	ds	ds	PROPN
dpc-4232	51	12	,	,	PUNCT
dpc-4232	51	13	rigopoulou	rigopoulou	ADJ
dpc-4232	51	14	ei	ei	PROPN
dpc-4232	51	15	,	,	PUNCT
dpc-4232	51	16	burroughs	burroughs	PROPN
dpc-4232	51	17	ak	ak	PROPN
dpc-4232	51	18	.	.	PROPN
dpc-4232	51	19	primary	primary	ADJ
dpc-4232	51	20	biliary	biliary	NOUN
dpc-4232	51	21	cirrhosis	cirrhosis	NOUN
dpc-4232	51	22	associated	associate	VERB
dpc-4232	51	23	with	with	ADP
dpc-4232	51	24	systemic	systemic	ADJ
dpc-4232	51	25	sclerosis	sclerosis	NOUN
dpc-4232	51	26	:	:	PUNCT
dpc-4232	51	27	diagnostic	diagnostic	ADJ
dpc-4232	51	28	and	and	CCONJ
dpc-4232	51	29	clinical	clinical	ADJ
dpc-4232	51	30	challenges	challenge	NOUN
dpc-4232	51	31	.	.	PUNCT
dpc-4232	52	1	int	int	NOUN
dpc-4232	52	2	j	j	PROPN
dpc-4232	52	3	rheumatol	rheumatol	NOUN
dpc-4232	52	4	.	.	PUNCT
dpc-4232	53	1	2011;2011:976427	2011;2011:976427	NUM
dpc-4232	53	2	.	.	PUNCT
dpc-4232	54	1	doi:10.1155	doi:10.1155	NOUN
dpc-4232	54	2	/2011/976427	/2011/976427	PUNCT
dpc-4232	55	1	5	5	X
dpc-4232	55	2	.	.	PUNCT
dpc-4232	55	3	naranjo	naranjo	PROPN
dpc-4232	55	4	m	m	PROPN
dpc-4232	55	5	,	,	PUNCT
dpc-4232	55	6	hassoun	hassoun	NOUN
dpc-4232	55	7	pm	pm	NOUN
dpc-4232	55	8	.	.	PUNCT
dpc-4232	56	1	systemic	systemic	ADJ
dpc-4232	56	2	sclerosis	sclerosis	NOUN
dpc-4232	56	3	-	-	PUNCT
dpc-4232	56	4	associated	associate	VERB
dpc-4232	56	5	pulmonary	pulmonary	ADJ
dpc-4232	56	6	hypertension	hypertension	NOUN
dpc-4232	56	7	:	:	PUNCT
dpc-4232	56	8	spectrum	spectrum	NOUN
dpc-4232	56	9	and	and	CCONJ
dpc-4232	56	10	impact	impact	NOUN
dpc-4232	56	11	.	.	PUNCT
dpc-4232	56	12	  	  	SPACE
dpc-4232	57	1	diagnostics	diagnostic	NOUN
dpc-4232	57	2	(	(	PUNCT
dpc-4232	57	3	basel	basel	PROPN
dpc-4232	57	4	)	)	PUNCT
dpc-4232	57	5	.	.	PUNCT
dpc-4232	58	1	2021;11(5):911	2021;11(5):911	NOUN
dpc-4232	58	2	.	.	PUNCT
dpc-4232	59	1	published	publish	VERB
dpc-4232	59	2	2021	2021	NUM
dpc-4232	59	3	may	may	AUX
dpc-4232	59	4	20	20	NUM
dpc-4232	59	5	.	.	PUNCT
dpc-4232	59	6	doi:10.3390	doi:10.3390	PROPN
dpc-4232	59	7	/diagnostics11050911	/diagnostics11050911	PUNCT